| architectural proteins | proteins playing a structural role in chromatin organization, include linker and core histone proteins and insulator proteins |
| acetylated histone protein | an epigenetic marker; an indicator of transcriptional competence |
| BBB | blood–brain barrier |
| BDNF | brain-derived neurotrophic factor |
| BETi(s) | BET inhibitor(s) of transcription factors of the BRD family |
| BRD | bromodomain [bromo- and extra-terminal motif (BET) domains] family of proteins (BRD1, BRD2, BRD3, BRD4, and BRDT) that bind to acetylated histone and promote the recruitment of macromolecular complexes with an increase in DNA transcriptional competence; belong to the functional class of readers |
| CB1 | cannabinoid receptor 1 |
| CBP | cyclic adenosine monophosphate response element-binding protein [CREB-binding protein]; transcriptional coactivator |
| CCL2 | C-C motif ligand 2; chemokine |
| ChIP | chromatin immunoprecipitation; protocols for profiling chemical modification of chromatin using immunoprecipitating methods |
| chromatin accessibility | the degree to which nuclear macromolecules are able to physically contact chromatinized DNA and is determined by the occupancy and topological organization of nucleosomes and other chromatin-binding factors that regulate access to the DNA |
| chromatin-binding factors | non-histone macromolecules binding to DNA (either directly or indirectly) |
| CNS | central nervous system |
| CpG | cytosine–guanine site; a dinucleotide sequence subject to preferred methylation; CpG sequences are predominantly concentrated in non-coding regions of the genome (CpG islands [CpG island]) and are associated with promoter DNA regions |
| CRP | C-reactive protein |
| CXCL1/10 | C-X-C motif ligand 1/10; chemokine |
| DNA | deoxyribonucleic acid |
| DNMT | DNA methyltransferase; methyltransferase of the DNMT3a type is represented by several isoforms and is responsible for de novo methylation, and DNMT1 (and DNMT3b)—interact with methylated loci; DNMT belongs to the functional class of writers |
| DNMTi(s) | DNMT inhibitor(s) |
| enhancer | a non-coding regulatory region of DNA, which, after binding of transcription factors to it, stimulates gene transcription |
| epigenome (epigenetic landscape) | a set of epigenetic phenomena in a cell at the estimated time |
| euchromatin | areas of decondensed, transcriptionally competent state of chromatin |
| EWASs | epigenome-wide association studies |
| GWASs | genome-wide association studies |
| H | histone proteins (H2A, H2B, H3, H4), constituting, in the form of dimers, a nucleosome complex |
| HAT | histone acetyltransferase; belongs to the functional group of writers; in general, HAT increases gene expression |
| HATi(s) | HAT inhibitor(s) |
| HDAC | histone deacetylase; HDACs are epigenetic erasers and make the DNA less accessible to transcription factors; the HDAC family includes zinc-dependent enzymes of the HDACI, HDACII, HDACIV, and NAD+-dependent HDACIII classes (sirtuins, SIRT) |
| HDACi(s) | HDAC inhibitor(s) |
| heterochromatin | areas of condensed, transcriptionally incompetent state of chromatin (DNA and histone proteins) |
| HIF1 | hypoxia-inducible factor 1 |
| IGF2 | insulin-like growth factor 2 |
| IL-6 | interleukin-6; has both pro- and anti-inflammatory activities depending on the tissue type |
| insulator | a non-coding protein-binding regulatory DNA sequence that regulates inter-chromosomal (enhancer-blocking insulators) and intra-chromosomal (barrier to the spread of neighboring heterochromatin) interactions within a particular DNA locus, flanked by insulators |
| KDM | lysine-specific demethylase [lysine demethylase]; KDM belongs to the functional class of erasers |
| KDMi(s) | KDM inhibitor(s) |
| KMT | lysine histone methyltransferase; KMT belongs to the functional class of writers |
| KMTi(s) | KMT inhibitor(s) |
| MAO B | monoamine oxidase B |
| MMP9 | matrix metalloproteinase 9 |
| methylated cytosine DNA (5mC, 5-methylcytosine) | epigenetic marker; an indicator of transcriptional incompetence; 5hmC—5-hydroxymethylcytosine, derivative of 5mC acting in further oxidation |
| ncRNA | non-coding functionally active RNA sequences [non-coding RNA]; the most important regulators of the epigenome are microRNAs [miRNAs], enhancer and long-length non-coding RNAs [eRNAs and lncRNAs] |
| NGF | nerve growth factor |
| NGS | next-generation sequencing; massively parallel DNA and RNA sequencing methods providing ultra-high throughput, scalability, and speed of analysis |
| nucleosome (complex) | the main structure-forming element of chromatin, an octamer of histone proteins encircled by approximately 147 DNA bp; together the composition and post-translational modification of nucleosomes regulate chromatin accessibility |
| p75(NTR) | p75 neurotrophin receptor, mediating a set of signaling pathways, including caspase-dependent signaling |
| PCAF | p300/CBP-associated factor, regulates crosstalk-dependent acetylation of histone H3 by distal site recognition |
| PGC1α | peroxisome proliferator-activated receptor gamma coactivator 1-alpha; transcriptional coactivator |
| PK/PD | pharmacokinetics and pharmacodynamics |
| PPARδ | peroxisome proliferator-activated receptor delta; nuclear hormone receptor |
| promoter | non-coding DNA region that binds to RNA polymerase and helper proteins initiating the transcription |
| PUFA(s) | polyunsaturated fatty acid(s) |
| RNA | ribonucleic acid |
| ROS | reactive oxygen species |
| STAT3 | signal transducer and activator of transcription 3 |
| TAD | topologically associated domain; a genomic region that self-interacts to form a three-dimensional structure, which determines the possibility of active interaction of regulatory elements (promoter–enhancer loops) and the transcriptional competence of a particular DNA locus |
| TF(s) | transcription factor(s); non-histone protein(s) binding directly to DNA and controlling the transcription rates |
| TET proteins | ten-eleven translocation proteins; enzymes that hydroxylate methylated cytosine (5mC); TET proteins belong to the functional class of erasers |
| TNF-α | tumor necrosis factor alpha; cytokine |